Steady State Global Bioequivalence Study of Amphotericin B Liposome for Injection 50 mg/ Vial in Fed Condition
Clinical trial NCT03636659 · COMPLETED
Trial details
- NCT number
- NCT03636659
- Sponsor
- Aurobindo Pharma Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-02
- Primary completion
- 2019-04-05
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.